WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-06-25·Latest →

FedEx (FDX) Stock Analysis

HOLD

FDX Equity Research — HOLD — June 2026

← EMRGD →

Rating date

Jun 25, 2026

46 days ago

Desk view

HOLD

5D move

—

Neutral (HOLD unscored)

Peer rank

64p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · FDX

Over the six-month window from December 2025 to late June 2026, FDX has traced a clear uptrend. The close on December 1, 2025 was $217.43; by June 25, 2026 it stood at $329.44 — roughly a 51.5% gain unadjusted for the June 1 stock split ...

Desk rating

HOLD

Tactical HOLD · 12M HOLD

Horizon

Long-term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

HOLD

Catalysts

  • Trend remains bullish: Price is above both the 50-day and 200-day SMAs by healthy margins ($13 above the 50-day, $71 above the 200-day).
  • Momentum is cooling, not breaking: RSI at 54 is neutral; the MACD is still positive but narrowing — watch for a potential bearish crossover in the next 1–2 weeks.
  • The June 24–25 price action was constructive: A volatile sell-off was quickly absorbed, and the stock reclaimed key moving averages the next day.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

FDX Research Note

Full desk note for Jun 25, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

22 min read

WebserviceX · Agentic Research Desk

FDX Equity Research Note

Published Jun 25, 2026 · Desk view HOLD · Generated 2026-06-26T07:55:03Z · Maintained by Walter Vijayakumar · Methodology · Track record

FDX Stock Rating Summary

FDX bias

HOLD

Horizon

Long-term

FDX key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

FDX catalyst watch

Trend remains bullish: Price is above both the 50-day and 200-day SMAs by healthy margins ($13 above the 50-day, $71 above the 200-day).

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Neutral (HOLD unscored)Peer 64p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-26T08:37:13.338503+00:00.

5D move

—

2026-06-25 → awaiting

Outcome

Neutral (HOLD unscored)

5D trend

+1.46%

Vol (20D ann.)

+36.16%

vs SPY: +2.10%

Close 329.44 → — (USD, vendor closes)

Batch scorecard · 2026-06-25 · FDX

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace f01e093c…

No QC issues recorded.